ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Allograft TLR9 is Required for Endogenous Donor-Reactive Memory CD8 T Cell Activation in High-Risk Cardiac Allografts to Mediate CTLA-4Ig Resistant Graft Rejection

E. H. Koritzinsky, D. Ueda, H. Tsuda, S. Miyari, R. L. Fairchild

Inflammation and Immunity, Cleveland Clinic, Cleveland, OH

Meeting: 2022 American Transplant Congress

Abstract number: 186

Keywords: Graft-infiltrating lymphocytes, Ischemia, T cell activation

Topic: Basic Science » Basic Science » 08 - Innate Immunity; Chemokines, Cytokines, Complement

Session Information

Session Name: Innate Immunity, Chemokines, Cytokines, and Complement

Session Type: Rapid Fire Oral Abstract

Date: Sunday, June 5, 2022

Session Time: 5:30pm-7:00pm

 Presentation Time: 5:40pm-5:50pm

Location: Hynes Room 309

*Purpose: Prolonged allograft cold ischemic storage (CIS) and subsequent increased ischemia-reperfusion injury (IRI) following solid organ transplant act through innate immune pathways that promote early activation of endogenous donor-reactive memory T cells to express effector functions to mediate CTLA-4Ig-resistant allograft rejection. Here, we investigated the role of innate immune ligands and receptors in IRI and their impact on this memory T cell activation and CTLA-4Ig resistant rejection.

*Methods: Mouse complete MHC-mismatched heart allografts were subjected to long (8hr) or short (0.5hr) CIS before heterotopic transplant. Infiltration and proliferation of endogenous donor-reactive memory T cells in allografts was assessed by flow cytometry. Plasma mitochondrial DNA was measured using a custom TaqMan qPCR assay. IFN-γ producing donor-reactive T cells in the spleen were quantified by ELISPOT.

*Results: Recipients of WT allografts subjected to long CIS had significantly elevated plasma mitochondrial DNA (mtDNA) as early as 12hr post-transplant (2.6-fold) compared to recipients of allografts subjected to short CIS. Because mtDNA is a TLR9 ligand, we then explored how long CIS affects expression of TLR9 versus other TLRs. On D2 post-transplant, WT allografts subjected to long CIS had significantly increased TLR9 (2.3-fold), but not TLR4 or TLR7, expression compared to WT allografts subjected to short CIS. Endogenous donor-reactive memory T cell activation on D2 in allografts subjected to long CIS was markedly reduced in TLR9 KO allografts compared to WT allografts. Allografts subjected to long CIS from TLR9 KO donors and transplanted into untreated recipients showed no survival benefit compared to allografts from WT donors (MST 7.5 vs 7 days). Consistent with this, numbers of splenic donor-reactive T cells producing IFN-γ on D7 did not differ between recipients of TLR9 KO and WT allografts, further indicating that graft TLR9 deficiency does not alter the generation of de novo donor-reactive T cell responses. In contrast, allografts from TLR9 KO donors subjected to long CIS had significantly prolonged survival in recipients conditioned with CTLA-4Ig on D0 and +1 compared to high-risk WT allografts (MST 59 vs 28 days).

*Conclusions: IRI induced release of mtDNA and activation of TLR9 signaling represent novel targets for abrogating CTLA-4Ig resistant endogenous donor-reactive memory T cell activation within high-risk allografts.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Koritzinsky EH, Ueda D, Tsuda H, Miyari S, Fairchild RL. Allograft TLR9 is Required for Endogenous Donor-Reactive Memory CD8 T Cell Activation in High-Risk Cardiac Allografts to Mediate CTLA-4Ig Resistant Graft Rejection [abstract]. Am J Transplant. 2022; 22 (suppl 3). https://atcmeetingabstracts.com/abstract/allograft-tlr9-is-required-for-endogenous-donor-reactive-memory-cd8-t-cell-activation-in-high-risk-cardiac-allografts-to-mediate-ctla-4ig-resistant-graft-rejection/. Accessed May 18, 2025.

« Back to 2022 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences